Enveric Biosciences Inc vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while iShares 20 Plus Year Treasury Bond ETF trades at $83.96. Which is the better fit depends on your goals.
| ENVB | TLT | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | — |
52-Week High | $17.40 | $92.06 |
52-Week Low | $1.28 | $83.02 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
The iShares 20+ Year Treasury Bond ETF (TLT) trades at $83.80, down 0.33% on the day, with technical indicators showing a bearish trend as moving averages signal strong selling pressure. Recent news highlights comparisons with other fixed-income ETFs and discussions about Treasury rate risk, while the fund continues its regular dividend distribution schedule through mid-2026.
TLT presents a defensive fixed-income opportunity amid market volatility, offering exposure to long-term Treasury bonds with current yields significantly higher than pre-crisis levels. However, investors face duration risk from potential Fed policy shifts and competition from higher-yielding alternatives, requiring careful consideration of interest rate sensitivity.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →